Distributed

No. 18-378

Merck & Co., Inc., et al. v. Gilead Sciences, Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Brief of respondent Gilead Sciences, Inc. in opposition filed.

Brief amicus curiae of Samuel L. Bray filed.

Brief amicus curiae of Celgene Corporation filed.

Motion to extend the time to file a response is granted and the time is extended to and including November 23, 2018.

Motion to extend the time to file a response from October 24, 2018 to November 23, 2018, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due October 24, 2018)

Application (18A51) granted by The Chief Justice extending the time to file until September 21, 2018.

Application (18A51) to extend the time to file a petition for a writ of certiorari from July 24, 2018 to September 21, 2018, submitted to The Chief Justice.

Parties

Merck & Co., Inc., et al., Petitioner, represented by Jeffrey Alan Lamken

Gilead Sciences, Inc., Respondent, represented by E. Joshua Rosenkranz

Amici Curiae

Celgene Corporation, Amicus Curiae, represented by Jennifer Loraine Swize

Samuel L. Bray, Amicus Curiae, represented by David A. White

 
Last updated: December 13, 2018